Clinical Efficacy and Safety of MB LuxuryⓇ Product Containing Epigallocathecin Gallate (EGCG) on Erythema, Melanin, and Skin Hydration

Clinical trial NCT07725900 · COMPLETED

Trial details

NCT number: NCT07725900
Sponsor: Naniek Widyaningrum
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hyperpigmentation Dry Skin Erythema

Start date: 2025-12-01
Primary completion: 2026-03-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.